Work

A phase 1 study of B7H3 CAR-T cells administered intracranially in recurrent glioblastoma.

Year: 2025

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.16_suppl.2018

Authors: Gordon Li, Brian R. Stocksdale, Kun-Wei Song, Jasia Mahdi, Kelly Tanner, Sophie Bertrand, Michael Iv, Zachary Threlkeld, Sneha Ramakrishna, Bita Sahaf, Emily Egeler, Vivek Charu, Ramya Tunuguntla, Kate Therkelsen, Seema Nagpal, Michael Lim, Michelle Monje, Brian Scott, Crystal Mackall, Reena Parada Thomas

Institutions: Stanford University, Stanford Medicine

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: California Institute for Regenerative Medicine

Award: Phase I Trial of Locoregionally Delivered Autologous B7-H3 CAR T Cells (B7-H3CART) in Adults with Recurrent Glioblastoma Multiforme

OpenAlex ID: W4410817040

Cites:

Cited by: 8

Related to: 10